ITCI
BNP Paribas Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-519,083
| Closed | -$43.4M | – | 920 |
|
|
2024
Q4 | $43.4M | Buy |
519,083
+64,545
| +14% | +$5.39M | 0.11% | 201 |
|
|
2024
Q3 | $33.3M | Buy |
454,538
+109,892
| +32% | +$8.04M | 0.08% | 235 |
|
|
2024
Q2 | $23.6M | Buy |
344,646
+79,049
| +30% | +$5.41M | 0.06% | 270 |
|
|
2024
Q1 | $18.4M | Buy |
+265,597
| New | +$18.4M | 0.05% | 315 |
|